» Authors » Jose Valero-Rosa

Jose Valero-Rosa

Explore the profile of Jose Valero-Rosa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 119
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Gomez E, Moreno Sorribas S, Valero-Rosa J, Blanca A, Mesa J, Salguero J, et al.
Diagnostics (Basel) . 2021 Aug; 11(8). PMID: 34441270
Introduction: Our aim was to assess the value of adding standard biopsy to targeted biopsy in cases of suspicious multiparametric magnetic resonance imaging (mp-MRI) and also to evaluate when a...
2.
Salguero J, Gomez-Gomez E, Valero-Rosa J, Carrasco-Valiente J, Mesa J, Martin C, et al.
Korean J Radiol . 2020 Dec; 22(4):559-567. PMID: 33289358
Objective: To evaluate the impact of multiparametric magnetic resonance imaging (mpMRI) before confirmatory prostate biopsy in patients under active surveillance (AS). Materials And Methods: This retrospective study included 170 patients...
3.
Gomez-Gomez E, Jimenez-Vacas J, Pedraza-Arevalo S, Lopez-Lopez F, Herrero-Aguayo V, Hormaechea-Agulla D, et al.
J Clin Med . 2019 Sep; 8(9). PMID: 31500112
Engrailed variant-2 (EN2) has been suggested as a potential diagnostic biomarker; however, its presence and functional role in prostate cancer (PCa) cells is still controversial or unknown. Here, we analyzed...
4.
Gomez-Gomez E, Carrasco-Valiente J, Campos-Hernandez J, Blanca-Pedregosa A, Jimenez-Vacas J, Ruiz-Garcia J, et al.
J Cell Mol Med . 2018 Nov; 23(2):934-942. PMID: 30450757
Recently, the influence that metabolic syndrome (MetS), hormonal alterations and inflammation might have on prostate cancer (PCa) risk has been a subject of controversial debate. Herein, we aimed to investigate...
5.
Gomez-Gomez E, Jimenez-Vacas J, Carrasco-Valiente J, Herrero-Aguayo V, Blanca-Pedregosa A, Leon-Gonzalez A, et al.
J Cell Mol Med . 2018 Sep; 22(11):5688-5697. PMID: 30256519
Early detection of PCa faces severe limitations as PSA displays poor-specificity/sensitivity. As we recently demonstrated that plasma ghrelin O-acyltransferase (GOAT)-enzyme is significantly elevated in PCa-patients compared with healthy-controls, using a...
6.
Hormaechea-Agulla D, Gahete M, Jimenez-Vacas J, Gomez-Gomez E, Ibanez-Costa A, L-Lopez F, et al.
Mol Cancer . 2017 Aug; 16(1):146. PMID: 28851363
Background: The Ghrelin-system is a complex, pleiotropic family composed of several peptides, including native-ghrelin and its In1-ghrelin splicing variant, and receptors (GHSR 1a/b), which are dysregulated in various endocrine-related tumors,...
7.
Hormaechea-Agulla D, Jimenez-Vacas J, Gomez-Gomez E, L-Lopez F, Carrasco-Valiente J, Valero-Rosa J, et al.
FASEB J . 2017 Jul; 31(11):4682-4696. PMID: 28705809
sst5TMD4, a splice variant of the sst5 gene, is overexpressed and associated with aggressiveness in various endocrine-related tumors, but its presence, functional role, and mechanisms of actions in prostate cancer...
8.
Gomez-Gomez E, Carrasco-Valiente J, Blanca-Pedregosa A, Barco-Sanchez B, Fernandez-Rueda J, Molina-Abril H, et al.
Urology . 2016 Nov; 102:85-91. PMID: 27840252
Objective: To externally validate the European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculator (RC) and to evaluate its variability between 2 consecutive prostate-specific antigen (PSA) values. Materials...
9.
Hormaechea-Agulla D, Gomez-Gomez E, Ibanez-Costa A, Carrasco-Valiente J, Rivero-Cortes E, L-Lopez F, et al.
Cancer Lett . 2016 Oct; 383(1):125-134. PMID: 27693462
Ghrelin-O-acyltransferase (GOAT) is the key enzyme regulating ghrelin activity, and has been proposed as a potential therapeutic target for obesity/diabetes and as a biomarker in some endocrine-related cancers. However, GOAT...